208 related articles for article (PubMed ID: 37201041)
1. Development and validation of an inflammatory response-related gene and clinical factor-based signature for predicting prognosis in gastric cancer.
Li S; Zhu J; Zhu T; Xu Y; Chen W; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Xu R; Shao Y
J Gastrointest Oncol; 2023 Apr; 14(2):599-616. PubMed ID: 37201041
[TBL] [Abstract][Full Text] [Related]
2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
4. Application of apoptosis-related genes in a multiomics-related prognostic model study of gastric cancer.
Xu C; Liu Z; Yan C; Xiao J
Front Genet; 2022; 13():901200. PubMed ID: 35991578
[TBL] [Abstract][Full Text] [Related]
5. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
7. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
8. A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies.
Ji D; Yang Y; Zhou F; Li C
Front Genet; 2022; 13():909175. PubMed ID: 36226177
[No Abstract] [Full Text] [Related]
9. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
PeerJ; 2024; 12():e16776. PubMed ID: 38274323
[TBL] [Abstract][Full Text] [Related]
10. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
PeerJ; 2024; 12():e16951. PubMed ID: 38436027
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel inflammatory-related gene signature to evaluate the prognosis of gastric cancer patients.
Hu JL; Huang MJ; Halina H; Qiao K; Wang ZY; Lu JJ; Yin CL; Gao F
World J Gastrointest Oncol; 2024 Mar; 16(3):945-967. PubMed ID: 38577477
[TBL] [Abstract][Full Text] [Related]
13. Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.
Liu X; Ren J; Zhou R; Wen Z; Wen Z; Chen Z; He S; Zhang H
BMC Cancer; 2023 Nov; 23(1):1106. PubMed ID: 37957566
[TBL] [Abstract][Full Text] [Related]
14. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
15. Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancer.
Shen X; Wang M; Chen W; Xu Y; Zhou Q; Zhu T; Wang G; Cai S; Han Y; Xu C; Wang W; Meng L; Sun H
Aging (Albany NY); 2023 Feb; 15(8):2891-2905. PubMed ID: 37100457
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
17. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.
Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H
Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672
[No Abstract] [Full Text] [Related]
18. Bioinformatics evaluation of a novel angiogenesis related genes-based signature for predicting prognosis and therapeutic efficacy in patients with gastric cancer.
Ma N; Li J; Lv L; Li C; Li K; Wang B
Am J Transl Res; 2022; 14(7):4532-4548. PubMed ID: 35958480
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
20. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
